Insulin Delivery
Consensus group: Providers, policies must support DIY artificial pancreas use
Health care providers should facilitate and support people with diabetes who choose to use a do-it-yourself automated insulin delivery system, working together with patients to set “realistic” goals and minimize any hypoglycemia risk.
‘Loop’ artificial pancreas software safe, effective with community support
The Loop open-source system for a do-it-yourself automated insulin delivery system can be initiated with community-developed resources and used safely and effectively by adults and children with type 1 diabetes, real-world data show.
Inhaled insulin reduces HbA1c, body weight in 24-week trial
Among adults with type 2 diabetes, inhaled insulin was associated with HbA1c reductions similar to those with insulin aspart, fewer hypoglycemic episodes and lower body weight, according to a study published in Endocrine Practice.
Bihormonal artificial pancreas system improves time in range, reduces hypoglycemia
Adults with type 1 diabetes using a fully closed-loop, bihormonal artificial pancreas experienced improved glucose response compared with insulin pump therapy without the need to provide meal or exercise announcements, outpatient data show.
Artificial pancreas may be safe for young children with type 1 diabetes
A modified version of an FDA-approved close-loop insulin delivery system may be effective for children aged 2 to 5 years with type 1 diabetes, according to study data published in Diabetes Technology & Therapeutics.
Smart insulin pens address challenges of multiple daily injection therapy
In this issue, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with nurse practitioner and diabetes care and education specialist Colleen Miller-Owen, MSN, APRN, CDCES, about the benefits of smart insulin pens for multiple daily injections.
FDA approves artificial pancreas for young children with type 1 diabetes
The FDA approved a next-generation hybrid closed-loop insulin delivery system for children aged 2 to 6 years with type 1 diabetes, according to an agency press release.
Educator support facilitates safe use of do-it-yourself artificial pancreas
People with diabetes who use a “hacked” hybrid closed-loop insulin delivery system continue to need clinical support to create initial settings, adjust settings over time and ensure such settings promote safety, according to a speaker.
FDA clears interoperable insulin pump for pediatric use
Next-generation artificial pancreas ‘user-friendly’ option for teens with type 1 diabetes
Adolescents and young adults with type 1 diabetes who used a next-generation hybrid closed-loop insulin delivery system saw improvements in HbA1c and time-in-range with no increase in hypoglycemia, study data show.